BDSX Q2 2024 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q2 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$18M+51.0% YoY

Gross Profit

$14M78.4% margin

Operating Income

-$8M-46.0% margin

Net Income

-$11M-60.3% margin

EPS (Diluted)

$-1.60

QoQ Revenue Growth

+21.0%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$21M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$116M

Total Liabilities

$80M

Stockholders' Equity

$36M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$12M	+51.0%
Gross Profit	$14M	$9M	+62.7%
Operating Income	-$8M	-$11M	+24.6%
Net Income	-$11M	-$13M	+19.1%

Revenue Segments

Diagnostic Tests

$17M100%